Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Heme oxygenase induction attenuates TNF-α-induced hypertension in pregnant rodents.

Frontiers in pharmacology

George EM, Stout JM, Stec DE, Granger JP.
PMID: 26347650
Front Pharmacol. 2015 Aug 17;6:165. doi: 10.3389/fphar.2015.00165. eCollection 2015.

Pre-eclampsia is a hypertensive disorder of pregnancy initiated by placental insufficiency and chronic ischemia. In response, several pathways activated in the placenta are responsible for the maternal syndrome, including increased production of the anti-angiogenic protein, sFlt-1, and inflammatory cytokines,...

Cite
George EM, Stout JM, Stec DE, et al. Heme oxygenase induction attenuates TNF-α-induced hypertension in pregnant rodents. Front Pharmacol. 2015;6:165doi: 10.3389/fphar.2015.00165.
George, E. M., Stout, J. M., Stec, D. E., & Granger, J. P. (2015). Heme oxygenase induction attenuates TNF-α-induced hypertension in pregnant rodents. Frontiers in pharmacology, 6165. https://doi.org/10.3389/fphar.2015.00165
George, Eric M, et al. "Heme oxygenase induction attenuates TNF-α-induced hypertension in pregnant rodents." Frontiers in pharmacology vol. 6 (2015): 165. doi: https://doi.org/10.3389/fphar.2015.00165
George EM, Stout JM, Stec DE, Granger JP. Heme oxygenase induction attenuates TNF-α-induced hypertension in pregnant rodents. Front Pharmacol. 2015 Aug 17;6:165. doi: 10.3389/fphar.2015.00165. eCollection 2015. PMID: 26347650; PMCID: PMC4538306.
Copy Download .nbib Format: NLM
Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis.

Vascular cell

George EM, Liu H, Robinson GG, Mahdi F, Perkins E, Bidwell GL.
PMID: 25653833
Vasc Cell. 2015 Jan 24;7(1):1. doi: 10.1186/s13221-014-0026-3. eCollection 2015.

BACKGROUND: Therapeutic angiogenesis with vascular endothelial growth factor (VEGF), delivered either via recombinant protein infusion or via gene therapy, has shown promise in preclinical models of various diseases including myocardial infarction, renovascular disease, preeclampsia, and neurodegenerative disorders. However, dosing,...

Cite
George EM, Liu H, Robinson GG, et al. Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis. Vasc Cell. 2015;7(1):1doi: 10.1186/s13221-014-0026-3.
George, E. M., Liu, H., Robinson, G. G., Mahdi, F., Perkins, E., & Bidwell, G. L. (2015). Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis. Vascular cell, 7(1), 1. https://doi.org/10.1186/s13221-014-0026-3
George, Eric M, et al. "Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis." Vascular cell vol. 7,1 (2015): 1. doi: https://doi.org/10.1186/s13221-014-0026-3
George EM, Liu H, Robinson GG, Mahdi F, Perkins E, Bidwell GL. Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis. Vasc Cell. 2015 Jan 24;7(1):1. doi: 10.1186/s13221-014-0026-3. eCollection 2015. PMID: 25653833; PMCID: PMC4316602.
Copy Download .nbib Format: NLM
Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsia.

Frontiers in pharmacology

Bidwell GL, George EM.
PMID: 25249978
Front Pharmacol. 2014 Sep 05;5:201. doi: 10.3389/fphar.2014.00201. eCollection 2014.

The last several decades have seen intensive research into the molecular mechanisms underlying the symptoms of preeclampsia. While the underlying cause of preeclampsia is believed to be defective placental development and resulting placental ischemia, it is only recently that...

Cite
Bidwell GL, George EM. Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsia. Front Pharmacol. 2014;5:201doi: 10.3389/fphar.2014.00201.
Bidwell, G. L., & George, E. M. (2014). Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsia. Frontiers in pharmacology, 5201. https://doi.org/10.3389/fphar.2014.00201
Bidwell, Gene L, and George, Eric M. "Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsia." Frontiers in pharmacology vol. 5 (2014): 201. doi: https://doi.org/10.3389/fphar.2014.00201
Bidwell GL, George EM. Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsia. Front Pharmacol. 2014 Sep 05;5:201. doi: 10.3389/fphar.2014.00201. eCollection 2014. PMID: 25249978; PMCID: PMC4155872.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries